Glycemic control indices (homeostasis model assessment of insulin resistance, hemoglobin A<sub>1c</sub> [HbA<sub>1c</sub> ], glycated albumin [GA] and chronic liver disease [CLD]-HbA<sub>1c</sub> [average of HbA<sub>1c</sub> and GA/3]) were also measured.
Greater understanding of the relationships between the dysbiosis of oral microbiota and the development of HBV-CLD might facilitate the development of non-invasive differential diagnostic procedures and targeted treatments of HBV-CLD patients harbouring specific oral phylotypes.
We determined HLA class I antigens and class II alleles in 130 hepatitis C virus (HCV)-infected patients (33 carriers with persistently normal alanine transaminase [ALT] values and 97 patients with chronic liver disease [CLD]).